EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Exploring the multiple therapeutic mechanisms and challenges of mesenchymal stem cell-derived exosomes in Alzheimer's disease

Ya-Nan Ma, Xiqi Hu, Kenji Karako, Peipei Song, Wei Tang, Ying Xia

BioScience Trends · 2024

DOI: 10.5582/bst.2024.01306 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift BioScience Trends, 2024. Verfasst von Ya-Nan Ma und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Haikou Affiliated Hospital of Central South University Xiangya School of Medicine, Haikou, China. Hauptthemen laut MEDLINE: Exosomes, Alzheimer Disease, Mesenchymal Stem Cells. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 161 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is a severe neurodegenerative disorder, and the current treatment options are limited. Mesenchymal stem cell-derived exosomes (MSC-Exos) have garnered significant attention due to their unique biological properties, showcasing tremendous potential as an acellular alternative therapy for AD. MSC-Exos exhibit excellent biocompatibility and low immunogenicity, enabling them to effectively cross the blood-brain barrier (BBB) and deliver therapeutic molecules directly to target cells. They are highly efficacious in delivering nucleic acid-based drugs. Moreover, the production process of MSC-Exos benefits from a high proliferation capacity and multilineage differentiation potential, allowing for production while maintaining a stable composition. Despite the significant theoretical advantages of MSC-Exos, their clinical use still faces multiple challenges, including cross-contamination during isolation and purification processes, the complexity of their components, and the presence of potential adverse paracrine factors. Future research needs to focus on optimizing separation and purification techniques, enhancing delivery methods to improve therapeutic efficacy, and performing detailed analyses of the components of MSC-Exos. In summary, MSC-Exos hold promise as an effective option for the treatment of AD and other neurodegenerative diseases, driving their clinical research and use in related fields.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesAlzheimer DiseaseMesenchymal Stem CellsHumansBlood-Brain BarrierAnimalsMesenchymal Stem Cell Transplantation

Stichwörter der Autor:innen

Alzheimer's diseaseblood-brain barriercell therapydrug deliveryimmunogenicitymesenchymal stem cell-derived exosomes

Autor:innen und Institutionen

  • Department of Neurosurgery, Haikou Affiliated Hospital of Central South University Xiangya School of Medicine, Haikou, China.
  • Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • National Center for Global Health and Medicine, Tokyo, Japan.

Zitieren

APA

Ma, Y. N., Hu, X., Karako, K., Song, P., Tang, W., & Xia, Y. (2024). Exploring the multiple therapeutic mechanisms and challenges of mesenchymal stem cell-derived exosomes in Alzheimer's disease. BioScience Trends. https://doi.org/10.5582/bst.2024.01306

Vancouver

Ma YN, Hu X, Karako K, Song P, Tang W, Xia Y. Exploring the multiple therapeutic mechanisms and challenges of mesenchymal stem cell-derived exosomes in Alzheimer's disease. BioScience Trends. 2024. doi:10.5582/bst.2024.01306

BibTeX
@article{Ma2024,
  author = {Ma, Ya-Nan and Hu, Xiqi and Karako, Kenji and Song, Peipei and Tang, Wei and Xia, Ying},
  title = {Exploring the multiple therapeutic mechanisms and challenges of mesenchymal stem cell-derived exosomes in Alzheimer's disease},
  journal = {BioScience Trends},
  year = {2024},
  doi = {10.5582/bst.2024.01306}
}
Kostenlos starten →